TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vitalis Pharma AS
Closing information (x1000 SEK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
109,769
|
101,571
|
95,474 |
| Financial expenses |
338
|
398
|
502 |
| Earnings before taxes |
28,671
|
17,609
|
20,275 |
| Total assets |
44,916
|
58,351
|
46,092 |
| Current assets |
8,870
|
19,420
|
16,169 |
| Current liabilities |
8,045
|
31,804
|
29,503 |
| Equity capital |
546
|
2,618
|
361 |
| - share capital |
317
|
308
|
286 |
| Employees (average) | 4 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
1.2%
|
4.5%
|
0.8% |
| Turnover per employee | 27,442 | ||
| Profit as a percentage of turnover |
26.1%
|
17.3%
|
21.2% |
| Return on assets (ROA) |
64.6%
|
30.9%
|
45.1% |
| Current ratio |
110.3%
|
61.1%
|
54.8% |
| Return on equity (ROE) |
5251.1%
|
672.6%
|
5616.3% |
| Change turnover |
5,051
|
-990
|
45,195 |
| Change turnover % |
5%
|
-1%
|
90% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.